126
Views
10
CrossRef citations to date
0
Altmetric
Biomarkers

sICAM-1 and TNF-α in Asthma and Rhinitis: Relationship with the Presence of Atopy

, M.D., Ph.D., , M.D., Ph.D. & , M.D., Ph.D.
Pages 660-666 | Published online: 15 Aug 2011

References

  • Hamelmann E, Rolinck-Werninghaus C, Wahn U. From IgE to anty-IgE: Where do we stand? Allergy 2002; 57:983–994.
  • Oettgen CH, Geha RS. IgE regulation and roles in asthma pathogenesis. J Allergy Clin Immunol 2001; 107:429–440.
  • Poole JA, Matangkasombut P, Rosenwasser LJ. Targeting the IgE molecule in allergic and asthmatic diseases: review of the IgE molecule and clinical efficacy. J Allergy Clin Immunol 2005; 114:375–385.
  • Holgate ST, Davies DE. Rethinking the pathogenesis of asthma. Immunity 2009; 31:362–367.
  • Barret NA, Austen KF. Innate cells and T helper 2 cell immunity in airway inflammation. Immunity 2009; 31:425–437.
  • Stanciu LA, Djukanovic R. The role of ICAM-1 on T-cells in the pathogenesis of asthma. Eur Respir J 1998; 11:949–957.
  • Iwasaki M, Saito K, Takemura M, Sekikawa K, Fujii H, Yamada Y, Wada H, Mizuta K, Seishima M, Ito Y. TNF-α contributes to the development of allergic rhinitis in mice. J Allergy Clin Immunol 2003; 112:134–140.
  • Kim H, Hwang JS, Woo CH, Kim EY, Kim TH, Cho KJ, Kim JH, Seo JM, Lee SS. TNF-alpha-induced up-regulation of intercellular adhesion molecule-1 is regulated by a Rac-ROS-dependent cascade in human airway epithelial cells. Exp Mol Med 2008; 40:167–175.
  • Berry M, Brightling C, Pavord I, Wardlaw AJ. TNF-α in asthma. Curr Opin Pharmacol 2007; 3:279–282.
  • Casale TB, Costa JJ, Galli SJ. TNF alpha is important in human lung allergic reactions. Am J Respir Cell Mol Biol 1996; 15:35–44.
  • Brozek JL, Bousquet J, Baena-Cagnani CE, Bonini S, Canonica GW, Casale TB, van Wijk RG, Ohta K, Zuberbier T, Schunemann HJ. Global Allergy and Asthma European Network, Grading of Recommendations Assessment, Development and Evaluation Working Group. Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines: 2010 Revision. J Allergy Clin Immunol 2010; 3:466–476.
  • Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2010:1–105. Available from: http://www. ginasthma.org/. data accessed 13.Feb.2011.
  • Cockroft DW, Killian DN, Mellon JJA, Hargreave FE. Bronchial reactivity to inhaled histamine: a method and clinical survey. Clin Allergy 1977; 7:235–243.
  • Sale R, Silvestri M, Battistini E, Defilippi AC, Sabatini F, Pecora S, Rossi GA. Nasal inflammation and bronchial reactivity to methacholine in atopic children with respiratory symptoms. Allergy 2003; 58:1171–1175.
  • Marguet C, Dean TP, Warner JO. Soluble intercellular adhesion molecule-1 (sICAM-1) and interferon-gamma in bronchoalveoar lavage fluid from children with airway diseases. Am J Respir Crit Care Med 2000; 162:1016–1022.
  • Shiota Y, Wilson JG, Marukawa M, Marukawa M, Ono T, Kaji M. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest 1996; 109:94–99.
  • Montefort S, Lai CKW, Kapahi P, Leung J, Lai KN, Chan HS, Haskard DO, Howarth PH, Holgate ST. Circulating adhesion molecules in asthma. Am J Respir Crit Care Med 1994; 149:1149–1152.
  • Gorska-Ciebiada M, Ciebiada M, Gorska M. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity. Ann Allergy Asthma Immunol 2006; 97:66–72.
  • Hughes JM, Rimmer SJ, Salome CM, Hodge L, Liu-Brennan D, Woolcock AJ, Armour CL. Eosinophilia, interleukin-5, and tumor necrosis factor-alpha in asthmatic children. Allergy 2001; 56:412–418.
  • Brass DM, Savov JD, Schwartz DA. Intercellular adhesion molecule-1 plays a pivotal role in endotoxin-induced airway disease. Chest 2003; 123:416.
  • Prieto L, Gutierrez V, Uixera S. Exhaled nitric oxide and bronchial responsiveness to adenosine 5’monophosphate in subjects with allergic rhinitis. Chest 2002; 121:1853–1859
  • Henriksen AH, Sue-Chu M, Lingaas Holmen T, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999; 13:301–306.
  • Alvarez MJ, Olaguibel JM, Garcia, BE, Rodríquez A, Tabar AI, Urbiola E. Airway inflammation in asthma and perennial allergic rhinitis. Relationship with nonspecific bronchial responsiveness and maximal airway narrowing. Allergy 2000; 55:355–362.
  • Amrani Y, Chen H, Panettieri A. Activation of tumor necrosis factor receptor 1 in airway smooth muscle: a potential pathway that modulates bronchial hyperresponsiveness in asthma? Respir Res 2000; 1: 49–53.
  • Obase Y, Shimoda T, Mitsuta K, Matsuo N, Matsuse H, Kohno S. Correlation between airway hyperresponsiveness and airway inflammation in young adult population: eosinophil, ECP, and cytokine levels in induced sputum. Ann Allergy Asthma Immunol 2001; 86:304–310.
  • Bentley AM, Menz G, Storz C, Robinson DS, Bradley B, Jeffery PK, Durham SR, Kay AB. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma: relationship to symptoms and bronchial responsiveness. Am Rev Respir Dis 1992; 146:500–506.
  • Bentley AM, Durham SR, Kay AB. Comparison of the immunopathology of extrinsic, intrinsic and occupational asthma. J Invest Allergol Clin Immunol 1994; 4:222–232.
  • Humbert M, Menz G, Ying S, Corrigan CJ, Robinson DS, Durham SR, Kay AB. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:528–533.
  • Handoyo S, Rosenwasser LJ. Asthma phenotypes. Curr Allergy Asthma Rep 2009; 9:439–445.
  • Humbert M, Durham SR, Ying S. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against “intrinsic” asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154:1497–1504.
  • Humbert M, Durham SR, Kimmitt P. Elevated expression of messenger ribonucleic acid encoding interleukin-13 in the bronchial mucosa of atopic and non-atopic subjects with asthma. J Allergy Clin Immunol 1997; 99:657–665.
  • Ying S, Meng Q, Zeibecoglou K. Eosinophil chemotactic chemokines (eotaxin, eotaxin 2, RANTES, monocyte chemoattractant protein-3 (MCP-3 and MCP-4) and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999; 163:6321–6329.
  • Menz GS, Ying S, Durham SR. Molecular concepts of IgE-initiated inflammation in atopic and non-atopic asthma. Allergy 1998; 53:15–21.
  • Itami DM, Latinne D, Bazin H. Immunoglobulin E is not required for but enhances airway inflammation and hyperresponsiveness. Allergy 2003; 58:1117–1124.
  • Romanet-Manet S, Charpin D, Magnan A, Lanteaume A, Vervloet D. Allergic vs. nonallergic asthma: what makes the difference? Allergy 2002; 57:607–613.
  • Ulrik CS, Baker V, Divsken A. A 10 year follow-up of 180 adults with bronchial asthma: factors important for the decline in lung function. Thorax 1992; 47:14–18.
  • Inouye T, Tarlo S, Broder I, Corey P, Davies G, Leznoff A, Mintz S, Thomas P. Severity of asthma in skin test-negative and skin test-positive patients. J Allergy Clin Immunol 1985; 75:313–319.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.